|
Dec 20
|
Argenx Crashes 25% As The Setbacks Mount For Its Hallmark Drug, Vyvgart
|
|
Dec 20
|
Argenx autoimmune drug study fails in blow to expansion hopes
|
|
Dec 20
|
argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus
|
|
Dec 8
|
Why is Argenx (ARGX) a Suitable Investment Option?
|
|
Dec 3
|
12 Stocks Billionaire Steve Cohen Just Bought and Sold
|
|
Dec 1
|
Several Catalysts Pushed argenx SE (ARGX) in Q3
|
|
Nov 28
|
Argenx Stock Crashes On An Unexpected Failure For Its Biggest Drug
|
|
Nov 28
|
These 2 Stocks Are Falling in a Fading Rally
|
|
Nov 28
|
UPDATE 2-November rally in European stocks stalls after comments from ECB officials
|
|
Nov 28
|
argenx Reports Topline Results from ADVANCE-SC Study of VYVGART Hytrulo in Primary Immune Thrombocytopenia
|
|
Nov 7
|
Q3 2023 Halozyme Therapeutics Inc Earnings Call
|
|
Nov 7
|
Here’s Why You Should Consider Investing in Argenx SE (ARGX)
|
|
Sep 17
|
New S&P 500 Entrant Airbnb And DKNG Lead 5 Stocks Near Buy Points
|
|
Sep 15
|
How IBD Stock Of The Day Argenx, A Top-Notch Biotech, Is Dominating — With One Drug
|
|
Sep 15
|
argenx Announces Positive CHMP Opinion for Subcutaneous Efgartigimod for Generalized Myasthenia Gravis
|
|
Aug 9
|
Halozyme (HALO) Q2 Earnings & Revenues Beat, 2023 View Raised
|